HCWB HCW Biologics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HCWB

Price (delayed)

$1.66

Market cap

$3.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$18.29

Enterprise value

$8.87M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 34
Highlights
HCWB's EPS has soared by 80% year-on-year and by 61% since the previous quarter
HCW Biologics's equity has increased by 29% from the previous quarter
The net income has dropped by 144% since the previous quarter but it has soared by 51% year-on-year
HCW Biologics's quick ratio has shrunk by 56% YoY and by 43% QoQ
HCW Biologics's gross margin has decreased by 3.4% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.hcwbiologics.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of HCWB

HCWB stock price

How has the HCW Biologics stock price performed over time
Intraday
-8.29%
1 week
-17.41%
1 month
-23.85%
1 year
-93.17%
YTD
-71.48%
QTD
-66.73%

Financial performance

How have HCW Biologics's revenue and profit performed over time
Revenue
$6.69M
Gross profit
$6.45M
Operating income
-$7.68M
Net income
-$5.58M
Gross margin
96.4%
Net margin
-83.5%
The net income has dropped by 144% since the previous quarter but it has soared by 51% year-on-year
The company's net margin has shrunk by 139% QoQ but it has surged by 99% YoY
HCWB's operating margin has soared by 98% YoY and by 6% from the previous quarter
The operating income has increased by 37% year-on-year and by 3.7% since the previous quarter

Price vs fundamentals

How does HCWB's price correlate with its fundamentals

Growth

What is HCW Biologics's growth rate over time

Valuation

What is HCW Biologics stock price valuation
P/E
N/A
P/B
0.25
P/S
0.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.33
HCWB's EPS has soared by 80% year-on-year and by 61% since the previous quarter
HCW Biologics's equity has increased by 29% from the previous quarter
HCWB's price to sales (P/S) is 99% less than its last 4 quarters average of 69.6 and 99% less than its 5-year quarterly average of 53.0

Efficiency

How efficient is HCW Biologics business performance
HCWB's return on invested capital has dropped by 196% since the previous quarter but it has surged by 58% year-on-year
HCWB's ROS has soared by 99% year-on-year
The ROE is up by 46% since the previous quarter
The ROA is down by 20% QoQ and by 11% YoY

Dividends

What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCWB.

Financial health

How did HCW Biologics financials performed over time
HCWB's total assets is 38% greater than its total liabilities
HCW Biologics's quick ratio has shrunk by 56% YoY and by 43% QoQ
The company's current ratio fell by 45% YoY and by 33% QoQ
The company's debt is 12% lower than its equity
HCW Biologics's debt to equity has surged by 101% YoY but it has decreased by 23% QoQ
HCW Biologics's equity has increased by 29% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.